Example: Heart Attack

Search clinical trials for: Hydralazine

Total 58 results

NCT03423810

Completed

Assessing a Dose-Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients

Conditions: Polycystic Kidney Diseases
NCT04217135

Recruiting

The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation

Conditions: Systolic Heart Failure Stage D (Disorder); Mitral Regurgitation
NCT02228408

Unknown status

Safety and Cardiovascular Efficacy of Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD

Conditions: Chronic Hemodialysis (ESRD)
NCT02050529

Completed

Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.

Conditions: Hypertension, Pregnancy Induced; Hydralazine Adverse Reaction; Pre-eclampsia; Pre-eclampsia Superimposed Pre-existing Hypertension
NCT04435210

Completed

Efficacy of Nifedipine Versus Hydralazine in Management of Severe Hypertension in Pregnancy

Conditions: Hypertension
NCT01822808

Unknown status

Bi Treatment With Hydralazine/Nitrates Versus Placebo in Africans Admitted With Acute Heart Failure

Conditions: Acute Heart Failure; Left Ventricular Dysfunction
NCT00575978

Withdrawn

Hydralazine as Demethylating Agent in Breast Cancer

Conditions: Breast Cancer
NCT00533299

Unknown status

Hydralazine Valproate for Ovarian Cancer

Conditions: Ovarian Cancer
NCT00575640

Withdrawn

Hydralazine as a Demethylating Agent in Rectal Cancer

Conditions: Rectal Cancer
NCT01538875

Completed

Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of Pregnancy

Conditions: Hypertension, Pregnancy Induced
NCT02343393

Unknown status

Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study

Conditions: Cardio-Renal Syndrome
NCT00996060

Completed

Use of Hydralazine and Valproic Acid in Advanced Solid Tumor Malignancies

Conditions: Lung Cancer
NCT00532818

Unknown status

Hydralazine Valproate for Cervical Cancer

Conditions: Metastatic Cervical Cancer
NCT00404326

Completed

Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer

Conditions: Cervical Cancer
NCT00395655

Terminated

Hydralazine and Valproate Added to Chemotherapy for Breast Cancer

Conditions: Locally Advanced Breast Cancer
NCT00404508

Completed

A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid Tumors

Conditions: Refractory Solid Tumors
NCT00607477

Terminated

Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension

Conditions: Treatment Induced Hypertension
NCT01516346

Completed

Vasodilator Therapy for Heart Failure and Preserved Ejection Fraction

Conditions: Heart Failure; Congestive Heart Failure
NCT02933593

Withdrawn

Changes in Central Arterial Pressure When Comparing ACOG Hypertensive Urgency Protocols

Conditions: Hypertension
NCT02046395

Completed

Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus

Conditions: Type 2 Diabetes; Hypertension
NCT01356875

Unknown status

Treatment of Myelodysplastic Syndromes Comparing Hydralazine/Ac. Valproic and Supportive Care in Patients Not Candidates, Refractory and/or Intolerant to Intensive Chemotherapy

Conditions: Myelodysplastic Syndrome
NCT02281838

Recruiting

The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II

Conditions: Intracerebral Hemorrhage
NCT03514108

Recruiting

DANHEART (H-HeFT and Met-HeFT)

Conditions: Heart Failure; Diabetes
NCT00963976

Completed

Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial

Conditions: Intracerebral Hemorrhage
NCT04116112

Recruiting

Blood Pressure After Endovascular Stroke Therapy-II

Conditions: Acute Stroke; Endovascular Thrombectomy